Stay updated with breaking news from Zydus Gets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, Zydus said in a statement.